Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Adult Stem Cells to Treat Patients With Severe Leg Artery Disease (SCRIPT-CLI)

This study has been terminated.
(Failure to mobilize adequate CD34+ stem cells for minimum study treatment dose.)
Sponsor:
Information provided by (Responsible Party):
University of Wisconsin, Madison
ClinicalTrials.gov Identifier:
NCT00913900
First received: June 2, 2009
Last updated: December 4, 2014
Last verified: December 2014